Comparison

Myelin Basic Protein

Item no. 11-511-248716
Manufacturer GENWAY
Amount 0.2ml
Category
Type Proteins
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias GWB-92BD80
Similar products 11-511-248716
Available
Genway ID:
GWB-92BD80
Specificity:
Myelin Basic Protein > 90% Pure
Type of Product:
Purified Neuroscience Reagents
Inactivation:
Not applicable
Buffer:
Not applicableApplications Notes : Immunoreactivity is checked using polyclonal and monoclonal antibodies against MBP. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Concentration:
Concentration is lot specific Myelin Basic Protein. Contains 18. 5kDa and 14. 2kDa isoforms and their dimers (13. 5% SDS-PAGE non-reducing conditions)
Function:
The classic group of MBP isoforms (isoform 4-isoform 14) are with PLP the most abundant protein components of the myelin membrane in the CNS. They have a role in both its formation and stabilization. The smaller isoforms might have an important role in remyelination of denuded axons in multiple sclerosis. The non-classic group of MBP isoforms (isoform 1-isoform 3/Golli-MBPs) may preferentially have a role in the early developing brain long before myelination maybe as components of transcriptional complexes and may also be involved in signaling pathways in T-cells and neural cells. Differential splicing events combined with optional post-translational modifications give a wide spectrum of isomers with each of them potentially having a specialized function. Induces T-cell proliferation.
Subunit:
Homodimer; isoform 3 exists as a homodimer.
Subcellular Location:
Myelin membrane; Peripheral membrane protein; Cytoplasmic side. Note=Cytoplasmic side of myelin.
Tissue Specificity:
MBP isoforms are found in both the central and the peripheral nervous system whereas Golli-MBP isoforms are expressed in fetal thymus spleen and spinal cord as well as in cell lines derived from the immune system. Developmental Stage: Expression begins abruptly in 14-16 week old fetuses. Even smaller isoforms seem to be produced during embryogenesis; some of these persisting in the adult. Expression of isoform MBP2 is more evident at 16 weeks and its relative proportion declines thereafter.
Ptm:
Several charge isomers of MBP; C1 (the most cationic least modified and most abundant form) C2 C3 C4 C5 C6 C7 C8-A and C8-B (the least cationic form); are produced as a result of optional PTM such as phosphorylation deamidation of glutamine or asparagine arginine citrullination and methylation. C8-A and C8-B contain each two mass isoforms termed C8-A(H) C8-A(L) C8-B(H) and C8-B(L) (H) standing for higher and (L) for lower molecular weight. C3 C4 and C5 are phosphorylated. The ratio of methylated arginine residues decreases during aging making the protein more cationic.
Ptm:
The N-terminal alanine is acetylated (isoform 3 isoform 4 isoform 5 and isoform 6).
Ptm:
Arg-241 was found to be 6% monomethylated and 60% symmetrically dimethylated.
Disease:
The reduction in the surface charge of citrullinated and/or methylated MBP could result in a weakened attachment to the myelin membrane. This mechanism could be operative in demyelinating diseases such as chronical multiple sclerosis (MS) and fulminating MS (Marburg disease).
Similarity:
Belongs to the myelin basic protein family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.2ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close